MADRIGAL PHARMACEUTICALS, INC. Income Statement
MDGL / Health Care|12 years of annual SEC 10-K data (FY2012-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 12 fiscal years. All figures from audited SEC 10-K filings.
MADRIGAL PHARMACEUTICALS, INC. reported $958M in revenue and $288M in net loss for FY2025. Revenue has grown at a 96.5% compound annual rate over the past 13 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2014 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $958.4M | $180.1M | $0 | $0 | $0 | $0 | $0 | - | - | - | - | $147.0K |
| Cost of Revenue | - | $6.2M | $0 | $0 | - | - | - | - | - | - | - | - |
| SG&A Expense | $813.8M | $435.1M | $108.1M | $48.1M | $37.3M | $21.9M | $22.6M | $15.3M | $7.7M | $9.3M | $15.7M | $11.7M |
| R&D Expense | $388.5M | $236.7M | $272.4M | $245.4M | $205.2M | $184.8M | $72.3M | $25.4M | $24.4M | $15.9M | $68.2M | $49.4M |
| Operating Income | -$300.1M | -$497.9M | -$380.5M | -$293.6M | -$242.5M | -$206.7M | -$95.0M | -$40.7M | -$32.1M | -$25.2M | -$84.0M | -$60.9M |
| Interest Expense | - | - | $2.3M | $4.0M | $0 | $0 | - | - | - | $1.2M | - | - |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - | - | - | - |
| Net Income | -$288.3M | -$465.9M | -$373.6M | -$295.4M | -$241.8M | -$202.2M | -$83.9M | -$32.8M | -$31.2M | -$26.4M | - | - |
| EPS (Basic) | -$19.99 | -$17.23 | -$14.63 | -$17.23 | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$19.99 | -$17.23 | -$14.63 | -$17.23 | -$5.45 | -$2.22 | - | - | - | - | -$1.06 | - |
| Shares Outstanding | 22.0M | 19.9M | 18.1M | 17.1M | 15.5M | 15.4M | 15.4M | 14.8M | 12.2M | 5.2M | 85.2M | 59.4M |
| Operating Margin | -31.3% | -276.4% | - | - | - | - | - | - | - | - | - | - |
| Profit Margin | -30.1% | -258.6% | - | - | - | - | - | - | - | - | - | - |